Literature DB >> 22104468

Transient receptor potential vanilloid type 1 and pain development.

Enza Palazzo1, Livio Luongo, Vito de Novellis, Francesco Rossi, Ida Marabese, Sabatino Maione.   

Abstract

Transient receptor potential vanilloid type 1 (TRPV1), a ligand-gated cation channel, is a polymodal nocitransducer widely expressed within pain transmitting/modulating areas of the peripheral and central nervous system. TRPV1 is both activated and sensitized by inflammatory endogenous mediators during inflammatory pain conditions and appears to be up regulated in neuropathic pain conditions. Owing to its role as pain integrator, its widespread expression in pain neuraxis and its involvement in pain development TRPV1 offers an exciting opportunity for therapeutic interventions in pain management. In particular, its supraspinal expression within the antinociceptive descending pathway, which includes periaqueductal grey (PAG) and rostral ventromedial medulla (RVM), represents an endogenous switch for extinguishing pain in pathological conditions. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22104468     DOI: 10.1016/j.coph.2011.10.022

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  25 in total

Review 1.  Transient receptor potential ion channels in primary sensory neurons as targets for novel analgesics.

Authors:  J Sousa-Valente; A P Andreou; L Urban; I Nagy
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

2.  Pain-enhancing mechanism through interaction between TRPV1 and anoctamin 1 in sensory neurons.

Authors:  Yasunori Takayama; Daisuke Uta; Hidemasa Furue; Makoto Tominaga
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-06       Impact factor: 11.205

3.  New trends in pain research: from basic research to clinical translation.

Authors:  Laura Berliocchi; Maria Maiarù; Damiana Scuteri; Maria Tiziana Corasaniti; Giacinto Bagetta
Journal:  Funct Neurol       Date:  2012 Oct-Dec

Review 4.  Cancer-induced bone pain: Mechanisms and models.

Authors:  A N Lozano-Ondoua; A M Symons-Liguori; T W Vanderah
Journal:  Neurosci Lett       Date:  2013-09-25       Impact factor: 3.046

Review 5.  [Neuropathic pain: pathophysiology, assessment, and therapy].

Authors:  C Sommer
Journal:  Schmerz       Date:  2013-12       Impact factor: 1.107

6.  Inhibitory effects of capsaicin on voltage-gated potassium channels by TRPV1-independent pathway.

Authors:  Rong Yang; Zhe Xiong; Changjin Liu; Lieju Liu
Journal:  Cell Mol Neurobiol       Date:  2014-03-04       Impact factor: 5.046

7.  Scaffolding by A-kinase anchoring protein enhances functional coupling between adenylyl cyclase and TRPV1 channel.

Authors:  Riad Efendiev; Alexis Bavencoffe; Hongzhen Hu; Michael X Zhu; Carmen W Dessauer
Journal:  J Biol Chem       Date:  2012-12-21       Impact factor: 5.157

8.  TRPV1 Antagonist Prevents Neonatal Sevoflurane-Induced Synaptic Abnormality and Cognitive Impairment in Mice Through Regulating the Src/Cofilin Signaling Pathway.

Authors:  Yuqiang Liu; Han Yang; Yifei Fu; Zhenglong Pan; Fang Qiu; Yanwen Xu; Xinping Yang; Qian Chen; Daqing Ma; Zhiheng Liu
Journal:  Front Cell Dev Biol       Date:  2021-07-07

9.  An NPY Y1 receptor antagonist unmasks latent sensitization and reveals the contribution of protein kinase A and Epac to chronic inflammatory pain.

Authors:  Weisi Fu; Tyler S Nelson; Diogo F Santos; Suzanne Doolen; Javier J P Gutierrez; Na Ye; Jia Zhou; Bradley K Taylor
Journal:  Pain       Date:  2019-08       Impact factor: 7.926

10.  Intervention of electroacupuncture on spinal p38 MAPK/ATF-2/VR-1 pathway in treating inflammatory pain induced by CFA in rats.

Authors:  Jian-Qiao Fang; Jun-Ying Du; Yi Liang; Jun-Fan Fang
Journal:  Mol Pain       Date:  2013-03-22       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.